Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002670055 | SCV003536513 | uncertain significance | Inborn genetic diseases | 2022-04-25 | criteria provided, single submitter | clinical testing | The c.281A>G (p.Q94R) alteration is located in exon 4 (coding exon 4) of the HACE1 gene. This alteration results from a A to G substitution at nucleotide position 281, causing the glutamine (Q) at amino acid position 94 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Genomic Medicine Center of Excellence, |
RCV004813218 | SCV005438478 | uncertain significance | Spastic paraplegia-severe developmental delay-epilepsy syndrome | 2024-12-18 | criteria provided, single submitter | clinical testing |